Author:
Piscolla E.,Hakiki B.,Pastò L.,Razzolini L.,Portaccio E.,Amato M. P.
Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology,Neurology
Reference8 articles.
1. Havla JB, Pellkofer HL, Meinl I et al (2012) Rebound of disease activity after withdrawal of Fingolimod (FTY720) treatment. Arch Neurol 69(2):262–264
2. Hakiki B, Portaccio E, Giannini M et al (2012) Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six cases. Mult Scler 18(11):1636–1639
3. Ghezzi A, Rocca MA, Baroncini D et al (2013) Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients. J Neurol 260(1):327–329
4. De Vera A, Kappos L, Zhang-Auberson L et al (2010) Pooled efficacy data demonstrate that fingolimod reduces multiple sclerosis relapse rate with no evidence of rebound after discontinuing treatment. Mult Scler 16(supplement 10):S 295
5. O’Connor PW, Goodman A, Kappos L et al (2011) Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis. Neurology 76:1858–1865
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献